<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32201498</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1746-0794</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Future virology</Title><ISOAbbreviation>Future Virol</ISOAbbreviation></Journal><ArticleTitle>STAT3 roles in viral infection: antiviral or proviral?</ArticleTitle><Pagination><StartPage>557</StartPage><EndPage>574</EndPage><MedlinePgn>557-574</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2217/fvl-2018-0033</ELocationID><Abstract><AbstractText>Signal transducer and activator of transcription 3 (STAT3) is a transcription factor which can be activated by cytokines, growth factor receptors, and nonreceptor-like tyrosine kinase. An activated STAT3 translocates into the nucleus and combines with DNA to regulate the expression of target genes involved in cell proliferation, differentiation, apoptosis and metastasis. Recent studies have shown that STAT3 plays important roles in viral infection and pathogenesis. STAT3 exhibits a proviral function in several viral infections, including those of HBV, HCV, HSV-1, varicella zoster virus, human CMV and measles virus. However, in some circumstances, STAT3 has an antiviral function in other viral infections, such as enterovirus 71, severe acute respiratory syndrome coronavirus and human metapneumovirus. This review summarizes the roles of STAT3 in viral infection and pathogenesis, and briefly discusses the molecular mechanisms involved in these processes.</AbstractText><CopyrightInformation>&#xa9; 2018 Future Medicine Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Zhangmei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Medical Molecular Virology of Ministries of Education &amp; Health, Shanghai Medical College of Fudan University, Shanghai 200032, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kunshan Center For Disease Control &amp; Prevention, 458 Tongfengxi Road, Kunshan, Jiangsu, 215301, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Medical Molecular Virology of Ministries of Education &amp; Health, Shanghai Medical College of Fudan University, Shanghai 200032, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kunshan Center For Disease Control &amp; Prevention, 458 Tongfengxi Road, Kunshan, Jiangsu, 215301, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology &amp; Parasitology, Laboratory of Medical Microbiology,&#xa0;Shanghai Medical College of Fudan University, 138 Yixueyuan R., Shanghai 200032, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology &amp; Parasitology, Laboratory of Medical Microbiology,&#xa0;Shanghai Medical College of Fudan University, 138 Yixueyuan R., Shanghai 200032, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Medical Molecular Virology of Ministries of Education &amp; Health, Shanghai Medical College of Fudan University, Shanghai 200032, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Medical Molecular Virology of Ministries of Education &amp; Health, Shanghai Medical College of Fudan University, Shanghai 200032, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Jian-Er</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Key Laboratory of Medical Molecular Virology of Ministries of Education &amp; Health, Shanghai Medical College of Fudan University, Shanghai 200032, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology &amp; Parasitology, Laboratory of Medical Microbiology,&#xa0;Shanghai Medical College of Fudan University, 138 Yixueyuan R., Shanghai 200032, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Medical Molecular Virology of Ministries of Education &amp; Health, Shanghai Medical College of Fudan University, Shanghai 200032, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology &amp; Parasitology, Laboratory of Medical Microbiology,&#xa0;Shanghai Medical College of Fudan University, 138 Yixueyuan R., Shanghai 200032, PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Future Virol</MedlineTA><NlmUniqueID>101278124</NlmUniqueID><ISSNLinking>1746-0794</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">JAK/STAT</Keyword><Keyword MajorTopicYN="N">STAT3</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>Financial &amp; competing interests disclosure This work was supported by the National Natural Science Foundation of China (NSFC. 31570156) and partially funded by the National Science and Technology Major Project on Infectious Diseases (2012ZX10004503-003).&#xa0;The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32201498</ArticleId><ArticleId IdType="pmc">PMC7079998</ArticleId><ArticleId IdType="doi">10.2217/fvl-2018-0033</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Duncan SA, Zhong Z, Wen Z, Darnell JE., Jr STAT signaling is active during early mammalian development. Dev. Dyn. 1997;208(2):190&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">9022056</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston PA, Grandis JR. STAT3 signaling: anticancer strategies and challenges. Mol. Interv. 2011;11(1):18&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063716</ArticleId><ArticleId IdType="pubmed">21441118</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy DE, Darnell JE., Jr Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 2002;3(9):651&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pubmed">12209125</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotthardt D, Sexl V. STATs in NK-cells: the good, the bad, and the ugly. Front. Immunol. 2017;18(7):694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5241313</ArticleId><ArticleId IdType="pubmed">28149296</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong AL, Yang ZD, Shen YC, Zhou J, Shen Q. Transcription factor STAT3 as a novel molecular target for cancer prevention. Cancers. 2014;6(2):926&#x2013;957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4074810</ArticleId><ArticleId IdType="pubmed">24743778</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S, Nishio Y, Inoue M, et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell. 1994;77(1):63&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">7512451</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer. 2009;9(11):798&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4856025</ArticleId><ArticleId IdType="pubmed">19851315</ArticleId></ArticleIdList></Reference><Reference><Citation>Kortylewski M, Xin H, Kujawski M, et al. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell. 2009;15(2):114&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673504</ArticleId><ArticleId IdType="pubmed">19185846</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerosa F, Baldani-Guerra B, Lyakh LA, et al. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 2008;205(6):1447&#x2013;1461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2413040</ArticleId><ArticleId IdType="pubmed">18490488</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal BB, Kunnumakkara AB, Harikumar KB, et al. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann. NY Acad. Sci. 2009;1171:59&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3141289</ArticleId><ArticleId IdType="pubmed">19723038</ArticleId></ArticleIdList></Reference><Reference><Citation>McCartney EM, Helbig KJ, Narayana SK, Eyre NS, Aloia AL, Beard MR. Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus. Hepatology. 2013;58(5):1558&#x2013;1568.</Citation><ArticleIdList><ArticleId IdType="pubmed">23703790</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells. Virology. 2004;327(2):169&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111732</ArticleId><ArticleId IdType="pubmed">15351204</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen N, Che X, Rajamani J, et al. Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. Proc. Natl. Acad. Sci. USA. 2012;109(2):600&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3258638</ArticleId><ArticleId IdType="pubmed">22190485</ArticleId></ArticleIdList></Reference><Reference><Citation>Waris G, Siddiqui A. Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function. J. Virol. 2002;76(6):2721&#x2013;2729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC135980</ArticleId><ArticleId IdType="pubmed">11861839</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh YM, Kim JK, Choi Y, Choi S, Yoo JY. Prediction and experimental validation of novel STAT3 target genes in human cancer cells. PLoS ONE. 2009;4(9):e6911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2731854</ArticleId><ArticleId IdType="pubmed">19730699</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam A, Shanmugam MK, Perumal E, et al. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochim. Biophys. Acta. 2013;1835(1):46&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">23103770</ArticleId></ArticleIdList></Reference><Reference><Citation>Zammarchi F, de Stanchina E, Bournazou E, et al. Antitumorigenic potential of STAT3 alternative splicing modulation. Proc. Natl Acad. Sci. USA. 2011;108(43):17779&#x2013;17784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203802</ArticleId><ArticleId IdType="pubmed">22006329</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K, Akira S. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 2000;11(3):199&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">10817963</ArticleId></ArticleIdList></Reference><Reference><Citation>Leaman DW, Leung S, Li X, Stark GR. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J. 1996;10(14):1578&#x2013;1588.</Citation><ArticleIdList><ArticleId IdType="pubmed">9002549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Herrmann A, Deng JH, et al. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell. 2009;15(4):283&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2777654</ArticleId><ArticleId IdType="pubmed">19345327</ArticleId></ArticleIdList></Reference><Reference><Citation>Tworkoski K, Singhal G, Szpakowski S, et al. Phosphoproteomic screen identifies potential therapeutic targets in melanoma. Mol. Cancer Res. 2011;9(6):801&#x2013;812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3117976</ArticleId><ArticleId IdType="pubmed">21521745</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Stark GR. Roles of unphosphorylated STATs in signaling. Cell Res. 2008;18(4):443&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">18364677</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan ZL, Guan YJ, Chatterjee D, Chin YE. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science. 2005;307(5707):269&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">15653507</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K, Noguchi K, Shi W, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl Acad. Sci. USA. 1997;94(8):3801&#x2013;3804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC20521</ArticleId><ArticleId IdType="pubmed">9108058</ArticleId></ArticleIdList></Reference><Reference><Citation>Niwa H, Burdon T, Chambers I, Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998;12(13):2048&#x2013;2060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC316954</ArticleId><ArticleId IdType="pubmed">9649508</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddahri F, Denanglaire S, Bureau F, et al. Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. Blood. 2009;113(11):2426&#x2013;2433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2656270</ArticleId><ArticleId IdType="pubmed">19020307</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurieva RI, Chung Y, Hwang D, et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity. 2008;29(1):138&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2556461</ArticleId><ArticleId IdType="pubmed">18599325</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogelzang A, McGuire HM, Yu D, Sprent J, MacKay CR, King C. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity. 2008;29(1):127&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">18602282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang XO, Panopoulos AD, Nurieva R, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 2007;282(13):9358&#x2013;9363.</Citation><ArticleIdList><ArticleId IdType="pubmed">17277312</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonzi T, Middleton G, Wyatt S, et al. Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons. Mol. Cell Neurosci. 2001;18(3):270&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">11591128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser PJ, Agrawal D, Hackney J, Pledger WJ. STAT3 activation accompanies keratinocyte differentiation. Cell Growth Differ. 1998;9(10):847&#x2013;855.</Citation><ArticleIdList><ArticleId IdType="pubmed">9790496</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano S, Itami S, Takeda K, et al. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 1999;18(17):4657&#x2013;4668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1171539</ArticleId><ArticleId IdType="pubmed">10469645</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys RC, Bierie B, Zhao L, Raz R, Levy D, Hennighausen L. Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology. 2002;143(9):3641&#x2013;3650.</Citation><ArticleIdList><ArticleId IdType="pubmed">12193580</ArticleId></ArticleIdList></Reference><Reference><Citation>Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21(1):11&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2834864</ArticleId><ArticleId IdType="pubmed">20018552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray JP, Marshall HD, Laidlaw BJ, Staron MM, Kaech SM, Craft J. Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity. 2014;40(3):367&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3992517</ArticleId><ArticleId IdType="pubmed">24631156</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel AM, Heimall J, Freeman AF, et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity. 2011;35(5):806&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3228524</ArticleId><ArticleId IdType="pubmed">22118528</ArticleId></ArticleIdList></Reference><Reference><Citation>Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol. Cell Biol. 2001;21(22):7721&#x2013;7730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC99943</ArticleId><ArticleId IdType="pubmed">11604508</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CH, Xu F, Chow S, et al. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Eur. J. Cancer. 2014;50(15):2560&#x2013;2569.</Citation><ArticleIdList><ArticleId IdType="pubmed">25087183</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Z, Li J, Yu X, et al. Polarization of monocytic myeloid-derived suppressor cells by hepatitis B surface antigen is mediated via ERK/IL-6/STAT3 signaling feedback and restrains the activation of T cells in chronic hepatitis B virus infection. J. Immunol. 2015;195(10):4873&#x2013;4883.</Citation><ArticleIdList><ArticleId IdType="pubmed">26416274</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Wu S, Wang J, et al. Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression. Cell Biosci. 2017;7:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5389182</ArticleId><ArticleId IdType="pubmed">28413603</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CH, Chen PJ, Jeng YM, Cheng AL, Huang LR, Cheng JC. Synergistic effect of radiation and interleukin-6 on hepatitis B virus reactivation in liver through STAT3 signaling pathway. Int. J. Radiat. Oncol. Biol. Phys. 2009;75(5):1545&#x2013;1552.</Citation><ArticleIdList><ArticleId IdType="pubmed">19327909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ching RHH, Sze KMF, Lau EYT, et al. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway. Oncotarget. 2017;8(14):23507&#x2013;23516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5410322</ArticleId><ArticleId IdType="pubmed">28186991</ArticleId></ArticleIdList></Reference><Reference><Citation>He P, Zhang D, Li H, et al. Hepatitis B virus X protein modulates apoptosis in human renal proximal tubular epithelial cells by activating the JAK2/STAT3 signaling pathway. Int. J. Mol. Med. 2013;31(5):1017&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3658604</ArticleId><ArticleId IdType="pubmed">23483208</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong G, Waris G, Tanveer R, Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl Acad. Sci. USA. 2001;98(17):9599&#x2013;9604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC55498</ArticleId><ArticleId IdType="pubmed">11481452</ArticleId></ArticleIdList></Reference><Reference><Citation>Waris G, Turkson J, Hassanein T, Siddiqui A. Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J. Virol. 2005;79(3):1569&#x2013;1580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC544105</ArticleId><ArticleId IdType="pubmed">15650183</ArticleId></ArticleIdList></Reference><Reference><Citation>Tacke RS, Tosello-Trampont A, Nguyen V, Mullins DW, Hahn YS. Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway. J. Biol. Chem. 2011;286(12):10847&#x2013;10855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3060535</ArticleId><ArticleId IdType="pubmed">21282107</ArticleId></ArticleIdList></Reference><Reference><Citation>Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, Lai MM. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J. Virol. 2006;80(14):7199&#x2013;7207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1489016</ArticleId><ArticleId IdType="pubmed">16809325</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, Jia M, Yuan J, et al. STAT3 regulated long noncoding RNAs lnc7SK and lncIGF2AS promote hepatitis C virus replication. Mol. Med. Rep. 2015;12(5):6738&#x2013;6744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626162</ArticleId><ArticleId IdType="pubmed">26328522</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, Zhang C, Yuan J, et al. Hepatitis C virus represses the cellular antiviral response by upregulating the expression of signal transducer and activator of transcription 3 through sponging microRNA122. Mol. Med. Rep. 2015;11(3):1733&#x2013;1737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4270330</ArticleId><ArticleId IdType="pubmed">25377467</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai N, Li H, Song H, et al. Hepatitis C virus induces MDSCs-like monocytes through TLR2/PI3K/AKT/STAT3 signaling. PLoS ONE. 2017;12(1):e0170516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5256909</ArticleId><ArticleId IdType="pubmed">28114346</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida T, Hanada T, Tokuhisa T, et al. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J. Exp. Med. 2002;196(5):641&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2194001</ArticleId><ArticleId IdType="pubmed">12208879</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarcar B, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase. Virology. 2004;322(1):51&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">15063116</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou JJ, Chen RF, Deng XG, et al. Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway. FEBS Lett. 2014;588(4):566&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pubmed">24462277</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong L, Li S, Yu X, et al. Hepatitis C virus and its protein NS4B activate the cancer-related STAT3 pathway via the endoplasmic reticulum overload response. Arch. Virol. 2016;161(8):2149&#x2013;2159.</Citation><ArticleIdList><ArticleId IdType="pubmed">27180099</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wu R, Liu Z, Fan J, Yang H. Enforced expression of microRNA-21 influences the replication of varicella-zoster virus by triggering signal transducer and activator of transcription 3. Exp. Ther. Med. 2014;7(5):1291&#x2013;1296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3991484</ArticleId><ArticleId IdType="pubmed">24940427</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitsma JM, Sato H, Nevels M, Terhune SS, Paulus C. Human cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus. J. Virol. 2013;87(19):10763&#x2013;10776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807375</ArticleId><ArticleId IdType="pubmed">23903834</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepiller Q, Abbas W, Kumar A, Tripathy MK, Herbein G. HCMV activates the IL-6-JAK-STAT3 axis in HepG2 cells and primary human hepatocytes. PLoS ONE. 2013;8(3):e59591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3608661</ArticleId><ArticleId IdType="pubmed">23555719</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YP, Tan YN, Wang ZL, et al. Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein&#x2013;Barr virus latent membrane protein 1 in nasopharyngeal carcinoma. Int. J. Mol. Med. 2008;21(2):153&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">18204781</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung CP, Raab-Traub N. Epstein&#x2013;Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3. J. Virol. 2008;82(11):5486&#x2013;5493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2395195</ArticleId><ArticleId IdType="pubmed">18367518</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung CP, Meckes DG, Jr, Raab-Traub N. Epstein&#x2013;Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta. J. Virol. 2011;85(9):4399&#x2013;4408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126279</ArticleId><ArticleId IdType="pubmed">21307189</ArticleId></ArticleIdList></Reference><Reference><Citation>Muromoto R, Ikeda O, Okabe K, et al. Epstein&#x2013;Barr virus-derived EBNA2 regulates STAT3 activation. Biochem. Biophys. Res. Commun. 2009;378(3):439&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">19032945</ArticleId></ArticleIdList></Reference><Reference><Citation>Incrocci R, Barse L, Stone A, et al. Epstein&#x2013;Barr virus latent membrane protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3. Virology. 2017;500:96&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127766</ArticleId><ArticleId IdType="pubmed">27792904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui VW, Wong EY, Ho Y, et al. STAT3 activation contributes directly to Epstein&#x2013;Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Int. J. Cancer. 2009;125(8):1884&#x2013;1893.</Citation><ArticleIdList><ArticleId IdType="pubmed">19588483</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Luo F, Li L, et al. STAT3 activation induced by Epstein&#x2013;Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 and ERK signaling. Eur. J. Cancer. 2010;46(16):2996&#x2013;3006.</Citation><ArticleIdList><ArticleId IdType="pubmed">20709526</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Shi Y, Yuan Q, et al. Epstein&#x2013;Barr virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J. Exp. Clin. Cancer Res. 2013;32:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3843577</ArticleId><ArticleId IdType="pubmed">24499623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Deng X, Wu M, Zhang G, Huang J. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells. FEBS Lett. 2014;588(9):1562&#x2013;1570.</Citation><ArticleIdList><ArticleId IdType="pubmed">24613926</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle D, Megyola C, El-Guindy A, et al. Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein&#x2013;Barr virus lytic cycle induction by HDAC inhibitors. J. Virol. 2010;84(2):993&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798381</ArticleId><ArticleId IdType="pubmed">19889776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill ER, Koganti S, Zhi J, et al. Signal transducer and activator of transcription 3 limits Epstein&#x2013;Barr virus lytic activation in B lymphocytes. J. Virol. 2013;87(21):11438&#x2013;11446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807321</ArticleId><ArticleId IdType="pubmed">23966384</ArticleId></ArticleIdList></Reference><Reference><Citation>Koganti S, Clark C, Zhi J, et al. Cellular STAT3 functions via PCBP2 to restrain Epstein&#x2013;Barr Virus lytic activation in B lymphocytes. J. Virol. 2015;89(9):5002&#x2013;5011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4403452</ArticleId><ArticleId IdType="pubmed">25717101</ArticleId></ArticleIdList></Reference><Reference><Citation>Punjabi AS, Carroll PA, Chen L, Lagunoff M. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J. Virol. 2007;81(5):2449&#x2013;2458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1865938</ArticleId><ArticleId IdType="pubmed">17151100</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong X, San JH, Kumar M, et al. Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. Biochem. Biophys. Res. Commun. 2003;306(2):616&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">12804610</ArticleId></ArticleIdList></Reference><Reference><Citation>Percario Z, Olivetta E, Fiorucci G, et al. Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery. J. Leukoc. Biol. 2003;74(5):821&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pubmed">12960275</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Huang L, Li J, et al. HIV infection in gastric epithelial cells. J. Infect. Dis. 2013;208(8):1221&#x2013;1230.</Citation><ArticleIdList><ArticleId IdType="pubmed">23852124</ArticleId></ArticleIdList></Reference><Reference><Citation>Del CM, Donninelli G, Varano B, Da SL, Masotti A, Gessani S. HIV-1 gp120 activates the STAT3/interleukin-6 axis in primary human monocyte-derived dendritic cells. J. Virol. 2014;88(19):11045&#x2013;11055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178808</ArticleId><ArticleId IdType="pubmed">25008924</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi S, Yamamoto N, Dewan MZ, et al. Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): shedding of soluble IL-6R and activation of STAT3 signaling. Int. J. Cancer. 2006;119(4):823&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">16557588</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada L, Nagano Y, Hasegawa A, et al. IL-10-mediated signals act as a switch for lymphoproliferation in human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways. PLoS Pathog. 2017;13(9):e1006597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5614654</ArticleId><ArticleId IdType="pubmed">28910419</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua JJ, Bhuvanakantham R, Chow VT, Ng ML. Recombinant non-structural 1 (NS1) protein of dengue-2 virus interacts with human STAT3beta protein. Virus Res. 2005;112(1&#x2013;2):85&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">15878791</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai YT, Chen YH, Chang DM, Chen PC, Lai JH. Janus kinase/signal transducer and activator of transcription 3 signaling pathway is crucial in chemokine production from hepatocytes infected by dengue virus. Exp. Biol. Med. 2011;236(10):1156&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pubmed">21893572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou W, Jin YH, Kang HS, Kim BS. Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function. J. Virol. 2014;88(15):8479&#x2013;8489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4135960</ArticleId><ArticleId IdType="pubmed">24829345</ArticleId></ArticleIdList></Reference><Reference><Citation>Du T, Zhou G, Roizman B. Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3. Proc. Natl Acad. Sci. USA. 2013;110(28):E2621&#x2013;E2628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3710862</ArticleId><ArticleId IdType="pubmed">23788661</ArticleId></ArticleIdList></Reference><Reference><Citation>Chucair-Elliott AJ, Conrady C, Zheng M, Kroll CM, Lane TE, Carr DJ. Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia. 2014;62(9):1418&#x2013;1434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4107000</ArticleId><ArticleId IdType="pubmed">24807365</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsia HC, Stopford CM, Zhang Z, Damania B, Baldwin AS. Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection. J. Leukoc. Biol. 2017;101(4):1053&#x2013;1064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5346178</ArticleId><ArticleId IdType="pubmed">27965384</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia D, Rahbar R, Chan RW, et al. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PLoS ONE. 2010;5(11):e13927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2978095</ArticleId><ArticleId IdType="pubmed">21085662</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahony R, Gargan S, Roberts KL, et al. A novel anti-viral role for STAT3 in IFN-alpha signalling responses. Cell Mol. Life Sci. 2017;74(9):1755&#x2013;1764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11107673</ArticleId><ArticleId IdType="pubmed">27988795</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui KP, Li HS, Cheung MC, et al. Highly pathogenic avian influenza H5N1 virus delays apoptotic responses via activation of STAT3. Sci Rep. 2016;6:28593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4921847</ArticleId><ArticleId IdType="pubmed">27344974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulane CM, Rodriguez JJ, Parisien JP, Horvath CM. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J. Virol. 2003;77(11):6385&#x2013;6393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC155014</ArticleId><ArticleId IdType="pubmed">12743296</ArticleId></ArticleIdList></Reference><Reference><Citation>Palosaari H, Parisien JP, Rodriguez JJ, Ulane CM, Horvath CM. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 2003;77(13):7635&#x2013;7644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC164804</ArticleId><ArticleId IdType="pubmed">12805463</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizutani T, Fukushi S, Murakami M, et al. Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells. FEBS Lett. 2004;577(1&#x2013;2):187&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125663</ArticleId><ArticleId IdType="pubmed">15527783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitzel DN, Jaramillo RJ, Stout-Delgado H, Senft AP, Harrod KS. Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium. J. Gen. Virol. 2014;95(Pt 1):26&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5974310</ArticleId><ArticleId IdType="pubmed">24114793</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Wang R, Ma Z, et al. Porcine reproductive and respiratory syndrome virus antagonizes JAK/STAT3 signaling via nsp5, which induces STAT3 degradation. J. Virol. 2017;91(3):e02087-16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5244345</ArticleId><ArticleId IdType="pubmed">27881658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, Hilbrandt M, Marggraf K, et al. Protective function of STAT3 in CVB3-induced myocarditis. Cardiol. Res. Pract. 2012:437623. 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3366200</ArticleId><ArticleId IdType="pubmed">22675647</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Z, Wang Y, Bian L, Liu Q, Long JE. Enterovirus 71 antagonizes the antiviral activity of host STAT3 and IL-6R with partial dependence on virus-induced miR-124. J. Gen. Virol. 2017;98(12):3008&#x2013;3025.</Citation><ArticleIdList><ArticleId IdType="pubmed">29120300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieu KG, Brice A, Wiltzer L, et al. The rabies virus interferon antagonist P protein interacts with activated STAT3 and inhibits Gp130 receptor signaling. J Virol. 2013;87(14):8261&#x2013;8265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3700209</ArticleId><ArticleId IdType="pubmed">23698294</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 2011;61(2):69&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Park JW, Kim TH, Koh DW, Lee WJ, Kim CM. Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2007;69(3):813&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pubmed">17524569</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133(2):647&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285346</ArticleId><ArticleId IdType="pubmed">17681183</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X, Dong S, Qiao F, et al. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene. 2013;32(27):3296&#x2013;3305.</Citation><ArticleIdList><ArticleId IdType="pubmed">23604124</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Zheng B, Han Q, Zhang C, Tian Z, Zhang J. Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma. Cancer Biol. Ther. 2016;17(4):449&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910934</ArticleId><ArticleId IdType="pubmed">26934469</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma NF, Lau SH, Hu L, et al. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin. Cancer Res. 2008;14(16):5061&#x2013;5068.</Citation><ArticleIdList><ArticleId IdType="pubmed">18698024</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva J, Nichols J, Theunissen TW, et al. Nanog is the gateway to the pluripotent ground state. Cell. 2009;138(4):722&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3437554</ArticleId><ArticleId IdType="pubmed">19703398</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattison J, Kool J, Uren AG, et al. Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach. Cancer Res. 2010;70(3):883&#x2013;895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2880710</ArticleId><ArticleId IdType="pubmed">20103622</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Xu X, He P. Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells. Mol. Med. Rep. 2011;4(1):25&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">21461558</ArticleId></ArticleIdList></Reference><Reference><Citation>Dienstag JL. Hepatitis B virus infection. N. Engl. J. Med. 2008;359(14):1486&#x2013;1500.</Citation><ArticleIdList><ArticleId IdType="pubmed">18832247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehata T, Omata M, Yokosuka O, Hosoda K, Ohto M. Variations in codons 84&#x2013;101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J. Clin. Invest. 1992;89(1):332&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC442853</ArticleId><ArticleId IdType="pubmed">1729279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoechst B, Voigtlaender T, Ormandy L, et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology. 2009;50(3):799&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6357774</ArticleId><ArticleId IdType="pubmed">19551844</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita D, Kondo T, Ohue S, et al. miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator. Cancer Res. 2015;75(6):1123&#x2013;1133.</Citation><ArticleIdList><ArticleId IdType="pubmed">25627976</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J, Ji H, Xiao F, et al. MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1. Biochem. Biophys. Res. Commun. 2017;483(1):578&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pubmed">27998770</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito I, Miyamura T, Ohbayashi A, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl Acad. Sci. USA. 1990;87(17):6547&#x2013;6549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC54573</ArticleId><ArticleId IdType="pubmed">2168552</ArticleId></ArticleIdList></Reference><Reference><Citation>Jitschin R, Braun M, Buttner M, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124(5):750&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">24850760</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang X, Song H, Zhang Q, Tu Z, Niu J. Hepatitis C virus regulates the production of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells through PI3K pathway and autocrine signaling. Clin. Immunol. 2016;164:57&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">26821305</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet. 2001;357(9267):1513&#x2013;1518.</Citation><ArticleIdList><ArticleId IdType="pubmed">11377626</ArticleId></ArticleIdList></Reference><Reference><Citation>Du T, Zhou G, Roizman B. HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs. Proc. Natl Acad. Sci. USA. 2011;108(46):18820&#x2013;18824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219146</ArticleId><ArticleId IdType="pubmed">22065742</ArticleId></ArticleIdList></Reference><Reference><Citation>Koganti S, de la Paz A, Freeman AF, Bhaduri-McIntosh S. B lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein&#x2013;Barr virus-driven cell proliferation. J. Virol. 2014;88(1):516&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3911703</ArticleId><ArticleId IdType="pubmed">24173212</ArticleId></ArticleIdList></Reference><Reference><Citation>Muromoto R, Okabe K, Fujimuro M, et al. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA. FEBS Lett. 2006;580(1):93&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">16364321</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Wang Q, Han T, et al. Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst. Cell Mol. Immunol. 2015;12(5):633&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579649</ArticleId><ArticleId IdType="pubmed">25176527</ArticleId></ArticleIdList></Reference><Reference><Citation>Puri M, Lemon K, Duprex WP, Rima BK, Horvath CM. A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting. J. Virol. 2009;83(13):6347&#x2013;6356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2698558</ArticleId><ArticleId IdType="pubmed">19386700</ArticleId></ArticleIdList></Reference><Reference><Citation>Messmer D, Bromberg J, Devgan G, Jacque JM, Granelli-Piperno A, Pope M. Human immunodeficiency virus type 1 Nef mediates activation of STAT3 in immature dendritic cells. AIDS Res. Hum. Retroviruses. 2002;18(14):1043&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pubmed">12396456</ArticleId></ArticleIdList></Reference><Reference><Citation>Vultur A, Arulanandam R, Turkson J, Niu G, Jove R, Raptis L. Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen. Mol. Biol. Cell. 2005;16(8):3832&#x2013;3846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1182320</ArticleId><ArticleId IdType="pubmed">15917293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni S, Zhao C, Feng GS, Paulson RF, Correll PH. A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/Ron receptor tyrosine kinase in response to Friend virus infection. Mol. Cell Biol. 2007;27(10):3708&#x2013;3715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1899994</ArticleId><ArticleId IdType="pubmed">17353274</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>